A detailed history of Black Rock Inc. transactions in Grifols Sa stock. As of the latest transaction made, Black Rock Inc. holds 2,277,896 shares of GRFS stock, worth $19.6 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
2,277,896
Previous 2,247,174 1.37%
Holding current value
$19.6 Million
Previous $15 Million 4.4%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$6.27 - $7.7 $192,626 - $236,559
30,722 Added 1.37%
2,277,896 $14.4 Million
Q1 2024

May 10, 2024

BUY
$5.47 - $11.38 $997,793 - $2.08 Million
182,412 Added 8.83%
2,247,174 $15 Million
Q4 2023

Feb 13, 2024

BUY
$7.71 - $11.56 $406,532 - $609,535
52,728 Added 2.62%
2,064,762 $23.9 Million
Q3 2023

Nov 13, 2023

SELL
$8.91 - $10.91 $1.56 Million - $1.9 Million
-174,591 Reduced 7.98%
2,012,034 $18.4 Million
Q2 2023

Aug 11, 2023

BUY
$7.14 - $9.29 $576,762 - $750,436
80,779 Added 3.84%
2,186,625 $20 Million
Q1 2023

May 12, 2023

SELL
$6.65 - $10.69 $696,753 - $1.12 Million
-104,775 Reduced 4.74%
2,105,846 $15.5 Million
Q4 2022

Feb 13, 2023

BUY
$5.96 - $8.53 $256,727 - $367,429
43,075 Added 1.99%
2,210,621 $18.8 Million
Q3 2022

Nov 14, 2022

SELL
$5.95 - $14.3 $2.39 Million - $5.74 Million
-401,528 Reduced 15.63%
2,167,546 $13.4 Million
Q2 2022

Aug 12, 2022

BUY
$10.6 - $13.28 $663,464 - $831,208
62,591 Added 2.5%
2,569,074 $30.5 Million
Q1 2022

May 12, 2022

BUY
$10.37 - $12.73 $6.14 Million - $7.53 Million
591,834 Added 30.91%
2,506,483 $29.3 Million
Q4 2021

Feb 10, 2022

BUY
$10.21 - $15.27 $1.67 Million - $2.5 Million
164,006 Added 9.37%
1,914,649 $21.5 Million
Q3 2021

Nov 09, 2021

SELL
$14.07 - $17.3 $193,420 - $237,823
-13,747 Reduced 0.78%
1,750,643 $25.6 Million
Q2 2021

Aug 11, 2021

BUY
$16.62 - $18.94 $29.3 Million - $33.4 Million
1,764,390 New
1,764,390 $30.6 Million

Others Institutions Holding GRFS

About Grifols SA


  • Ticker GRFS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 678,910,976
  • Market Cap $5.84B
  • Description
  • Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company operates through Bioscience, Hospital, Diagnostic, Bio Supplies, and Others divisions. The Bioscience division researches, develops, produces, and markets plasma-derived medicines and other innovative solut...
More about GRFS
Track This Portfolio

Track Black Rock Inc. Portfolio

Follow Black Rock Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.